Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus.
暂无分享,去创建一个
[1] P. Blankestijn,et al. Optimising glomerular filtration rate and effective renal plasma flow measurements using a simple pharmacokinetic model. , 1995, Clinical nephrology.
[2] D. de Zeeuw,et al. Glomerular preload and afterload reduction as a tool to lower urinary protein leakage: will such treatments also help to improve renal function outcome? , 1993, Journal of the American Society of Nephrology : JASN.
[3] B. Myers,et al. Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease. , 1992, Kidney international.
[4] B. Tucker. Early Onset of Increased Transcapillary Albumin Escape in Awake Diabetic Rats , 1990, Diabetes.
[5] J. Laragh,et al. Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus. , 1989, Clinical science.
[6] A. Woolf,et al. Effects of physiological infusion of atrial natriuretic factor on healthy subjects and patients with the nephrotic syndrome. , 1989, Nephron.
[7] S. Bloom,et al. HORMONAL RESPONSE TO BLOOD VOLUME EXPANSION IN DIABETIC SUBJECTS WITH AND WITHOUT AUTONOMIC NEUROPATHY , 1989, Clinical endocrinology.
[8] J. Williamson,et al. Mechanisms Underlying Atriopeptin‐Induced Increases in Hematocrit and Vascular Permeation in Rats , 1989, Circulation research.
[9] K. Mizuno,et al. Atrial natriuretic factor (ANF) increases urinary protein excretion in patients with essential hypertension: a possible role of ANF for renal handling of protein. , 1989, Biochemical and biophysical research communications.
[10] R. Zietse,et al. Effect of synthetic human atrial natriuretic peptide (102-126) in nephrotic syndrome. , 1988, Kidney international.
[11] J. McMurray,et al. The effect of atrial natriuretic factor on urinary albumin and beta 2-microglobulin excretion in man. , 1988, Journal of hypertension.
[12] L. Heinemann,et al. Atrial natriuretic factor in various stages of diabetic nephropathy. , 1988, The Journal of diabetic complications.
[13] R. Ardaillou,et al. Atrial natriuretic peptide in diabetic patients with microangiopathy. , 1988, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[14] B. Feldt-Rasmussen,et al. Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. , 1988, Kidney international.
[15] M. Schalekamp,et al. High concentrations of immunoreactive renin, prorenin and enzymatically‐active renin in human ovarian follicular fluid , 1988, British journal of obstetrics and gynaecology.
[16] J. Flier,et al. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. , 1987, The New England journal of medicine.
[17] M. Cohen,et al. Disturbances in Glomerular Basement Membrane Glycosaminoglycans in Experimental Diabetes , 1987, Diabetes.
[18] W. Deen,et al. Functional Nature of Glomerular Injury in Progressive Diabetic Glomerulopathy , 1987, Diabetes.
[19] V. Huxley,et al. Increased capillary hydraulic conductivity induced by atrial natriuretic peptide. , 1987, Circulation research.
[20] J. Fleming,et al. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney , 1986, Nature.
[21] B. Waeber,et al. Effect of atriopeptin III on hematocrit and volemia of nephrectomized rats. , 1986, The American journal of physiology.
[22] R. Cuneo,et al. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake. , 1986, The Journal of clinical endocrinology and metabolism.
[23] P. Erne,et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. , 1986, The New England journal of medicine.
[24] P. Weidmann,et al. Blood levels and renal effects of atrial natriuretic peptide in normal man. , 1986, The Journal of clinical investigation.
[25] B. Brenner,et al. Heteroporous model of glomerular size selectivity: application to normal and nephrotic humans. , 1985, The American journal of physiology.
[26] G. Martin,et al. Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocin-induced diabetic mice. , 1983, The Journal of biological chemistry.
[27] B. Myers,et al. Mechanisms of Proteinuria in Diabetic Nephropathy II: A Study of the Size-Selective Glomerular Filtration Barrier , 1983, Diabetes.
[28] H. Keen,et al. MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS , 1982, The Lancet.
[29] P. Watkins,et al. PROGRESSION OF DIABETIC NEPHROPATHY , 1979, The Lancet.
[30] Cockcroft Dw,et al. Prediction of Creatinine Clearance from Serum Creatinine , 1976 .
[31] H. H. P ARVING,et al. Transcapillary escape rate of albumin and plasma volume in short- and long-term juvenile diabetics. , 1973, Scandinavian journal of clinical and laboratory investigation.
[32] C. Mogensen. Urinary albumin excretion in early and long-term juvenile diabetes. , 1971, Scandinavian journal of clinical and laboratory investigation.
[33] K. Granath,et al. Molecular weight distribution analysis by gel chromatography on Sephadex. , 1967, Journal of chromatography.
[34] G. Schreiner,et al. Determination of Inulin by Means of Resorcinol , 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.